MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
about
Dysregulation of miR-15a and miR-214 in human pancreatic cancerRecent progress in pancreatic cancerAberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomaThe miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionSurgical and molecular pathology of pancreatic neoplasmsMicroRNA in pancreatic ductal adenocarcinoma and its precursor lesionsAppraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-AnalysismiRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A ReviewNoncoding RNAs and pancreatic cancerPrevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future DirectionsGenome-wide analysis of microRNA and mRNA expression signatures in cancerThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisCirculating RNAs as new biomarkers for detecting pancreatic cancerMicro-RNAs as diagnostic or prognostic markers in human epithelial malignanciesMicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancerRegulating miRNA by natural agents as a new strategy for cancer treatmentCan Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsRegulating the Regulators: microRNA and AsthmaIdentification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancerTissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancerMicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumorsNoncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.Identfication of key miRNAs in pancreatitis using bioinformatics analysis of microarray dataPancreatic cystic lesions: How endoscopic ultrasound morphology and endoscopic ultrasound fine needle aspiration help unlock the diagnostic puzzle.Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis.Strengths and limitations of laboratory procedures for microRNA detectionEpigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsMiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.Implication of microRNAs in drug resistance for designing novel cancer therapyMolecular signatures of pancreatic cancer.Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia.Targeting miRNAs for pancreatic cancer therapyHsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
P2860
Q21198870-048807F4-1D02-4781-8345-B9BEF937E18EQ24626346-BF4C771C-EB1C-4DB6-BB55-9B2B32ACDD8DQ24627680-7EEAF77B-1B74-423F-BDB4-796E668E00C7Q26744831-5DE0AADB-60D9-4FD9-AA2E-B864B59BCC19Q26748615-E506F42F-CD0D-4297-A1B0-EEAA5C5A27EBQ26769953-585D8166-FCB9-4ED9-9D1E-3A1439EE86C9Q26772056-48324A23-7A42-4D5F-B54C-F28E66EB46C6Q26774628-20DD5A14-DB87-4F93-9BF7-DD2EE135D4B9Q26774630-54036A32-E280-4AEF-927D-E2D1C8BC958EQ26783953-5532107C-80A6-41D1-8ABB-3104A969D89DQ26795603-69086096-39EA-4DAD-A9C2-E8D589AA4C65Q26800055-C0EBB2E0-FEA5-4E0A-ACF9-20453C90CB24Q26801191-454752D7-F741-418B-BB1F-616A7EC134CFQ26823077-83566E54-FE91-41E2-88B2-547AEFBC9955Q27022048-79268B06-47DA-4AF6-9345-26CE386B9948Q27026972-5D12674E-BCEE-42B3-9D26-97737A18835DQ28066454-EFCEF0FC-32BD-4961-87AF-32311E37DF9BQ28074465-392F40D5-0AB6-469F-9732-0069D520E2ABQ28382842-F447AC88-BFF7-4C13-AC8F-B7E94FAA25FFQ28473944-8AACBA80-6CDC-4644-B985-2CEF12EDEBDAQ28478758-05BB54DC-C0AD-446B-93F1-389BC185297FQ28731854-4BE1EBB7-F4BF-4DCA-940B-5B6AB4733591Q30241331-4841BED3-F62C-4E57-89FE-16E1606328FFQ30493254-D5E90047-D0E7-464E-A37F-5588BD531147Q30541314-2840AFDA-EB62-43C6-9252-562B8A2F4411Q31142190-6B954935-5E30-4A90-9783-0797059C5AF1Q33353791-D7F09479-DBF5-47D7-8FEB-38020F597D19Q33561359-87AE301B-3D24-4165-8653-A902401187FCQ33586516-B7030EBF-72DE-482E-8831-45FC8D9EE53CQ33618413-136D6F23-FDB5-4701-8AB3-A3BCA068517AQ33780712-8FEE8426-0CB8-4923-9C58-30545E7A2A2DQ33801377-9EF4F46F-8A96-44A9-B5AB-6165370D9946Q33850292-BB46D564-2FC4-4F62-8318-4026AC010F90Q33862088-F429307D-2AFC-4158-8EC1-98ECD34A18A5Q33889404-DF65E166-0C31-47DA-B15B-00A34E3C07A8Q33903223-D86F7323-D7B4-4CD7-9BFB-D2D859BF8564Q33918801-4AFE8671-931E-44FA-BA61-4A61A3D0A115Q33944966-0F09299E-E8FA-426D-A445-007831B8562FQ33962488-F74C4CFA-F6A8-46AA-8D00-6A2E28BBC2CBQ33991823-74CEFFE9-B75C-46B1-819B-C5DA14BEE40D
P2860
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@ast
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@en
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@nl
type
label
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@ast
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@en
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@nl
prefLabel
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@ast
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@en
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@nl
P2093
P2860
P3181
P356
P1476
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
@en
P2093
Anirban Maitra
G Johan Offerhaus
Georg Feldmann
Jan-Bart M Koorstra
Ji Kon Ryu
Joshua T Mendell
Michael E Mullendore
Michael G Goggins
Nils Habbe
Seung-Mo Hong
P2860
P3181
P356
10.4161/CBT.8.4.7338
P407
P577
2009-02-01T00:00:00Z